dantrolene has been researched along with Recrudescence in 15 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Dantrolene has a safe side-effect profile and a mechanism of action that makes it attractive as an option for treatment of cerebral vasospasm." | 5.51 | Intra-Arterial Dantrolene for Refractory Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage. ( Jahngir, M; Litofsky, NS; Nattanmai, P; Ortiz Torres, MJ; Qualls, K; Qureshi, AI, 2019) |
| "A PubMed search was conducted through March 2016 using available medical subject heading (MeSH) terms and keywords that included neuroleptic malignant syndrome, treatment, dantrolene, and bromocriptine." | 4.93 | Neuroleptic Malignant Syndrome. ( Cook, AM; Pileggi, DJ, 2016) |
| " Following initial improvement, she developed delayed rhabdomyolysis then haloperidol-induced neuroleptic malignant syndrome, which was treated with a total of 50 mg." | 3.78 | Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene. ( Hawryluck, LA; Kraeva, N; Riazi, S; Russell, T; Steel, AC, 2012) |
| "A fever of unknown origin developed in a patient with sequelae of acute encephalopathy who had received dantrolene for severe spasticity." | 3.74 | [Recurrent fever related to dantrolene sodium in a girl with sequelae of acute encephalopathy]. ( Fujikawa, Y; Komaki, H; Nakagawa, E; Oomi, T; Sasaki, M; Sugai, K, 2007) |
| "Neuroleptic malignant syndrome is a rare but potentially fatal reaction associated with neuroleptic drugs." | 2.38 | Neuroleptic malignant syndrome. ( Caroff, SN; Mann, SC, 1993) |
| "Dantrolene has a safe side-effect profile and a mechanism of action that makes it attractive as an option for treatment of cerebral vasospasm." | 1.51 | Intra-Arterial Dantrolene for Refractory Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage. ( Jahngir, M; Litofsky, NS; Nattanmai, P; Ortiz Torres, MJ; Qualls, K; Qureshi, AI, 2019) |
| "Some patients develop recrudescence after a malignant hyperthermia (MH) reaction, but it is not clear which patients are at risk." | 1.34 | Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions. ( Burkman, JM; Domino, KB; Posner, KL, 2007) |
| "Satoyoshi syndrome is a very rare disorder, characterized by progressive painful intermittent muscle spasms beginning in adolescence." | 1.31 | [A case of Satoyoshi syndrome complicating marginal gingivitis of the mandible and dislocation of the temporomandibular joint]. ( Matsumura, T; Shinno, S; Yokoe, M, 2002) |
| "The natural course of untreated neuroleptic malignant syndrome (NMS) does not usually exceed 3 weeks." | 1.28 | [Protracted recurrent neuroleptic malignant syndrome]. ( Delerue, O; Destée, A, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ortiz Torres, MJ | 1 |
| Jahngir, M | 1 |
| Qualls, K | 1 |
| Litofsky, NS | 1 |
| Nattanmai, P | 1 |
| Qureshi, AI | 1 |
| Pileggi, DJ | 1 |
| Cook, AM | 1 |
| Cummings, T | 1 |
| Der, T | 1 |
| Karsli, C | 1 |
| Russell, T | 1 |
| Riazi, S | 1 |
| Kraeva, N | 1 |
| Steel, AC | 1 |
| Hawryluck, LA | 1 |
| Matsumura, T | 1 |
| Yokoe, M | 1 |
| Shinno, S | 1 |
| Tsuchiya, N | 1 |
| Morimura, E | 1 |
| Hanafusa, T | 1 |
| Shinomura, T | 1 |
| Burkman, JM | 1 |
| Posner, KL | 1 |
| Domino, KB | 1 |
| Migita, T | 1 |
| Mukaida, K | 1 |
| Kawamoto, M | 1 |
| Kobayashi, M | 1 |
| Yuge, O | 1 |
| Oomi, T | 1 |
| Nakagawa, E | 1 |
| Fujikawa, Y | 1 |
| Komaki, H | 1 |
| Sugai, K | 1 |
| Sasaki, M | 1 |
| Caroff, SN | 1 |
| Mann, SC | 1 |
| Short, JA | 1 |
| Cooper, CM | 1 |
| Delerue, O | 1 |
| Destée, A | 1 |
| Sewell, DD | 1 |
| Jeste, DV | 1 |
| Gronert, GA | 1 |
| Ahern, CP | 1 |
| Milde, JH | 1 |
| Lesser, MS | 1 |
| Kahan, M | 1 |
| Brenner, R | 1 |
| Nayak, D | 1 |
3 reviews available for dantrolene and Recrudescence
| Article | Year |
|---|---|
Neuroleptic Malignant Syndrome.
Topics: Antipsychotic Agents; Dantrolene; Diagnosis, Differential; Humans; Mental Disorders; Neuroleptic Mal | 2016 |
Neuroleptic malignant syndrome.
Topics: Age Factors; Antipsychotic Agents; Dantrolene; Diagnosis, Differential; Dopamine Agents; Electric St | 1993 |
Neuroleptic malignant syndrome: a review.
Topics: Bromocriptine; Dantrolene; Diagnosis, Differential; Heat Exhaustion; Humans; Neuroleptic Malignant S | 1989 |
12 other studies available for dantrolene and Recrudescence
| Article | Year |
|---|---|
Intra-Arterial Dantrolene for Refractory Cerebral Vasospasm in Patients with Aneurysmal Subarachnoid Hemorrhage.
Topics: Adult; Dantrolene; Female; Humans; Infusions, Intra-Arterial; Middle Aged; Muscle Relaxants, Central | 2019 |
Repeated nonanesthetic malignant hyperthermia reactions in a child.
Topics: Administration, Intravenous; Dantrolene; Female; Humans; Infant; Malignant Hyperthermia; Muscle Rela | 2016 |
Ecstacy-induced delayed rhabdomyolysis and neuroleptic malignant syndrome in a patient with a novel variant in the ryanodine receptor type 1 gene.
Topics: Anesthetics, Inhalation; Antipsychotic Agents; Body Temperature; Caffeine; Central Nervous System St | 2012 |
[A case of Satoyoshi syndrome complicating marginal gingivitis of the mandible and dislocation of the temporomandibular joint].
Topics: Adolescent; Bone and Bones; Dantrolene; Gingivitis; Humans; Joint Dislocations; Joints; Male; Mandib | 2002 |
Postoperative neuroleptic malignant syndrome that occurred repeatedly in a patient with cerebral palsy.
Topics: Anesthesia, General; Antipsychotic Agents; Body Temperature; Cerebral Palsy; Child; Creatine Kinase; | 2007 |
Analysis of the clinical variables associated with recrudescence after malignant hyperthermia reactions.
Topics: Adolescent; Adult; Aged; Body Temperature; Case-Control Studies; Child; Child, Preschool; Dantrolene | 2007 |
Fulminant-type malignant hyperthermia in Japan: cumulative analysis of 383 cases.
Topics: Anesthetics; Dantrolene; Female; Humans; Incidence; Japan; Male; Malignant Hyperthermia; Recurrence | 2007 |
[Recurrent fever related to dantrolene sodium in a girl with sequelae of acute encephalopathy].
Topics: Acute Disease; Brain Diseases; Dantrolene; Female; Fever of Unknown Origin; Humans; Infant; Muscle R | 2007 |
Suspected recurrence of malignant hyperthermia after post-extubation shivering in the intensive care unit, 18 h after tonsillectomy.
Topics: Adult; Dantrolene; Disease Susceptibility; Humans; Male; Malignant Hyperthermia; Muscle Relaxants, C | 1999 |
[Protracted recurrent neuroleptic malignant syndrome].
Topics: Adult; Bromocriptine; Dantrolene; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Neu | 1990 |
Treatment of porcine malignant hyperthermia: lactate gradient from muscle to blood.
Topics: Animals; Bicarbonates; Carbon Dioxide; Dantrolene; Halothane; Lactates; Lactic Acid; Malignant Hyper | 1986 |
Dantrolene sodium as a possible prophylactic agent against N.M.S.
Topics: Adult; Dantrolene; Fluphenazine; Humans; Male; Neuroleptic Malignant Syndrome; Recurrence; Schizophr | 1986 |